Jeffrey Sparks, MD, MMSc

Financial relationships

  • Attribution:
    Self
    Type of financial relationship:
    Researcher
    Ineligible company:
    10x Genomics
    Topic:
    Cellular biomarkers
    Date added:
    05/04/2026
    Date updated:
    05/04/2026
  • Attribution:
    Self
    Type of financial relationship:
    Consultant
    Ineligible company:
    Boehringer Ingelheim
    Topic:
    Interstitial lung disease
    Date added:
    05/04/2026
    Date updated:
    05/04/2026
  • Attribution:
    Self
    Type of financial relationship:
    Consultant
    Ineligible company:
    Bristol Myers Squibb
    Topic:
    Rheumatoid arthritis
    Date added:
    05/04/2026
    Date updated:
    05/04/2026
  • Attribution:
    Self
    Type of financial relationship:
    Researcher
    Ineligible company:
    Johnson & Johnson
    Topic:
    Psoriatic arthritis
    Date added:
    05/04/2026
    Date updated:
    05/04/2026
  • Attribution:
    Self
    Type of financial relationship:
    Researcher
    Ineligible company:
    Sonoma Biotherapeutics
    Topic:
    Rheumatoid arthritis
    Date added:
    05/04/2026
    Date updated:
    05/04/2026
  • Attribution:
    Self
    Type of financial relationship:
    Consultant
    Ineligible company:
    AbbVie
    Topic:
    Rheumatoid arthritis
    Date added:
    05/04/2026
    Date updated:
    05/04/2026
  • Attribution:
    Self
    Type of financial relationship:
    Consultant
    Ineligible company:
    Anaptys
    Topic:
    Rheumatoid arthritis
    Date added:
    05/04/2026
    Date updated:
    05/04/2026
  • Attribution:
    Self
    Type of financial relationship:
    Advisor
    Ineligible company:
    AstraZeneca
    Topic:
    Rheumatoid arthritis
    Date added:
    05/04/2026
    Date updated:
    05/04/2026
  • Attribution:
    Self
    Type of financial relationship:
    Consultant
    Ineligible company:
    GSK
    Topic:
    Interstitial lung disease
    Date added:
    05/04/2026
    Date updated:
    05/04/2026
  • Attribution:
    Self
    Type of financial relationship:
    Consultant
    Ineligible company:
    Immunovant
    Topic:
    Rheumatoid arthritis
    Date added:
    05/04/2026
    Date updated:
    05/04/2026

Pages

Return to 2026 Florida Society of Rheumatology Annual Meeting